Hexaspray oromucosal spray 750 mg bottle 30 g

Instructions Hexaspray oromucosal spray 750 mg bottle 30 g

Composition

active ingredient: biclothymol;

1 bottle contains biclotimol 750 mg;

Excipients: benzyl alcohol, disodium edetate, ammonium glycyrrhizinate, star anise oil, sodium saccharin, microcrystalline cellulose, soy lecithin, glycerin, ethanol 95%, purified water, methyl parahydroxybenzoate (E 218).

Pressure-generating gas: nitrogen.

Dosage form

Oromucosal spray.

Main physicochemical properties: homogeneous beige suspension with a characteristic anise odor.

Pharmacotherapeutic group

Drugs used in throat diseases. ATX code R02A.

Pharmacological properties

Pharmacodynamics.

Antiseptic, analgesic and anti-inflammatory agent.

Biclotymol is a phenol derivative with antibacterial activity against staphylococci, streptococci, micrococci and corynebacteria. It coagulates microbial cell proteins. It also has anti-inflammatory and analgesic effects.

The drug is absorbed through the mucous membranes very slowly, which ensures its long-term presence in the oral cavity.

Indication

Local symptomatic treatment of infectious and inflammatory diseases of the oral cavity and nasopharynx: tonsillitis, pharyngitis, aphthous stomatitis, gingivitis, periodontitis.

Contraindication

Hypersensitivity. Children under 2.5 years of age (due to the risk of developing laryngospasm).

Interaction with other drugs and other types of interactions.

Not detected.

Application features

Use of the drug for more than 5 days may cause disruption of the homeostasis of the normal microflora of the oral cavity with the risk of spreading bacterial or fungal infection. Simultaneous use of other antiseptic agents should be avoided, as undesirable interactions (antagonism, inactivation) are possible.

In case of deterioration of the condition, in particular an increase in temperature, or if there is no improvement within 5 days, it is necessary to re-examine the patient and change the treatment tactics.

Use during pregnancy or breastfeeding

Adequate and well-controlled studies of the safety of the drug during pregnancy or breastfeeding have not been conducted.

Ability to influence reaction speed when driving vehicles or other mechanisms

No effect.

Method of administration and doses

Apply topically. When irrigating the oral cavity, the bottle should be held in an upright position. The bottle should be shaken before use.

For adults and children aged 2.5 years and over.

Adults and children over 2.5 years of age: 2 injections 3 times a day.

Treatment is limited to 5 days.

Children

The drug is not used in children under 2.5 years of age.

Overdose

Not detected.

Adverse reactions

Dermatological disorders

Very rare: allergic disorders - swelling of the lips, urticaria, skin rash, erythema, angioedema.

Due to the content of methyl parahydroxybenzoate and soy lecithin in the preparation, allergic reactions may develop in certain groups of patients.

Expiration date

5 years.

Storage conditions

Store in a place protected from light and out of the reach of children, at a temperature not exceeding 25 °C.

Packaging

Aerosol bottle with a capacity of 30 g in a cardboard box.

Vacation category

Without a prescription.

Producer

Bouchard Recordate Laboratories.

Location of the manufacturer and its business address

Mechatronic Park, 03410, Saint Victor, France.

Applicant

Bouchard Recordate Laboratories.